Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
The influencer has been sharing her postpartum health journey, adding GLP-1 medication to her Weight Watchers program.
Eli Lilly ( LLY 2.00%) recently announced stellar results from a phase 3 clinical trial, Triumph-4, which evaluated efficacy ...
LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.
The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...
Starting in 2026, people who are insured through Medicare will pay no more than $2,100 out of pocket on prescription drugs ...
Bariatric doctors who regularly prescribe GLP-1s share how long the worst Ozempic side effects last, and the best ways to ...
Health care stocks have been on a run lately, leading the S&P 500’s 11 sectors over the past three months with a gain of ...
There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results